Who We Are


Independently, we bring varied backgrounds with diverse expertise. Collectively, we are committed to discovering novel, alteration-specific therapies. Alterome is dedicated to relentlessly pushing the boundaries of cancer treatments to transform the lives of patients.

Founding Story

Brought Together for Patients

In January 2022, on the heels of a $64 million Series A funding, CEO Eric Murphy, called upon trusted colleagues who shared his commitment to developing life-changing therapies for patients with cancer, to solve cancer’s most difficult challenges. A team of experienced leaders in precision oncology drug development with a history of delivering marketed oncology small molecule drugs to patients answered the call and joined our Movement.

Our Values


We are accountable to ourselves to make each day matter, to our colleagues to ensure everything we do is with purpose, and to patients to deliver transformative therapies.


We are committed to achieving our Mission through the collective success of every member of the team. To achieve this, we must demonstrate integrity, humility, and respect for each other.


We are devoted to fighting cancer for the long haul; inspiring hope for a lifetime and extending the lives of patients. It is this sense of purpose that drives our unwavering resilience.


We seek to understand the myriad of experiences of our colleagues, our partners, our community, and individuals affected by cancer.


Developing transformative therapies for difficult to treat cancers demands the curiosity to ask why, the courage to try novel approaches, and the agility to achieve unprecedented results.


Tough challenges require relentless determination and a sense of urgency to solve. We give 100% of ourselves to create a meaningful impact for patients, and we continue forward until we have an answer.

Senior Leadership

Eric Murphy Headshot - Alterome Senior Leadership 2023

Eric Murphy

Co-Founder, CEO, & CSO
Scott Moorefield Headshot - Alterome Senior Leadership 2023

Scott Moorefield

Michael Bartberger Headshot - Alterome Senior Leadership 2023

Michael Bartberger

SVP, Head of Computational Chemistry
Elisabeth Gardiner Headshot - Alterome Senior Leadership 2023

Elisabeth Gardiner

SVP, Head of Biology
Sanjeev Thohan Headshot - Alterome Senior Leadership 2023

Sanjeev Thohan

SVP, Non-Clinical Research
America Thompson Headshot - Alterome Senior Leadership 2023

America Thompson

VP, Head of Finance
Xuefeng Zhu Headshot - Alterome Senior Leadership 2023

Xuefeng Zhu

VP, Medicinal Chemistry
Jim Cartoni Headshot - Alterome Senior Leadership 2023

Jim Cartoni

General Counsel

The A-Team

Nikki Alvarez Headshot - Alterome The A-Team 2023

Nikki Alvarez

Dir, Project Management
Jenn Dawson Headshot - Alterome The A-Team 2023

Jenn Dawson

Sr Dir, People and Culture
Kevin Fan Headshot - Alterome The A-Team 2023

Kevin Fan

Assoc Dir, Medicinal Chemistry
Greg Goodman Headshot - Alterome The A-Team 2023

Greg Goodman

Sr Dir, IT & Cybersecurity
Maureen Ibanez Headshot - Alterome The A-Team 2023

Maureen Ibanez

Principal Investigator, In Vitro Biology
Troy Smith Headshot - Alterome The A-Team 2023

Troy Smith

Sr Dir, Informatics
Noel Timple Headshot - Alterome The A-Team 2023

Noel Timple

Sr Dir, In Vivo Pharmacology
Breda Walsh Headshot - Alterome The A-Team 2023

Breda Walsh

Dir, Operations
Artie Zaragoza Headshot - Alterome The A-Team 2023

Artie Zaragoza

Sr Manager, Finance & Accounting

Board of Directors

Carl Gordon

Managing Partner, OrbiMed

Arjun Goyal

Co-Founder & Managing Director, Vida Ventures

Thilo Schroeder

Managing Partner, Nextech Invest

Eric Murphy

Co-Founder, CEO, & CSO

Ryan Corcoran

Co-Founder, SAB Chair

Board Observers

Sundeep Agrawal

General Partner, Colt Ventures

Aaron Davis

Co-Founder & CEO, Boxer Capital

Rich Heyman

Strategic Advisor

Scientific Advisory Board

Ryan Corcoran

SAB Chair, Massachusetts General Hospital, Harvard Medical School

Benjamin Cravatt

The Scripps Research Institute

Keith Flaherty, MD

Massachusetts General Hospital, Harvard Medical School

Paul Workman

Institute of Cancer Research, London


Our People Make the Difference!

We have come together as a Team; we COMMIT to our mission to DISCOVER life-changing therapies and INSPIRE hope for cancer patients. We believe that how we work together allows us to accomplish this goal in the best way possible. Everyone’s voice is heard. Challenge accepted. If you share our vision to transform the lives of cancer patients, come join us.


Several options to choose from, allowing employees to be their healthiest without worry about coverage costs to them and their families. Plus, supplemental coverage options.

401(k) with Matching

It is important for employees to consider their retirement savings. Alterome provides a 401(k) to all employees with a 4% match.


We will always encourage and support the growth of our employees through collaboration, training, mentorship, and the myriad of ways we wish to learn.

Community Work

Building Community

At Alterome, we are committed to giving back to our San Diego community. We are a proud Corporate Sponsor of Life Science Cares (LSC) San Diego, an organization that raises funds and coordinates partnerships to help organizations battle homelessness, hunger, poverty, and other social ailments. Through our partnership with LSC, Alterome employees strive to make a positive impact on our community, whether packing up boxes of fresh, healthy meals for food-insecure families, assembling back-to-school backpacks for students affected by homelessness, or building bikes to share the feelings of joy and freedom of a bike with underprivileged kids. We will continue our commitment to building strength and belonging within our community. “Alone we can do so little; Together, we can do so much.” Helen Keller